Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
04/2010
04/21/2010CN101696232A Peptidomimetic protease inhibitors
04/21/2010CN101695573A Method for producing pseudorabies living vaccines by using subculture cell source and product thereof
04/21/2010CN101695572A Method for producing pseudorabies attenuated vaccine by using bioreactor and pseudorabies attenuated vaccine product
04/21/2010CN101695571A Method for producing swine fever vaccine by using bioreactor and swine fever vaccine product
04/21/2010CN101695570A Univalent and bivalent inactivated vaccine for hand-foot-and-mouth disease and preparation method thereof
04/21/2010CN101695569A Univalent and bivalent gene engineered subunit vaccine for hand-foot-and-mouth disease and preparation method thereof
04/20/2010US7700350 for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells and to induce microfusion
04/20/2010US7700342 Lentiviral packaging constructs
04/20/2010US7700116 Method of inducing an immune response in a host by administering immunogenic compositions comprising UV-irradiated, psoralen-inactivated, desialated human immunodeficiency virus (HIV) particles devoid of CD55 and CD59 in the viral membrane
04/20/2010US7700104 Attenuated Salmonella SP12 mutants as antigen carriers
04/20/2010US7700103 Nucleotide sequences coding human papilloma viral like particles (Hpv 58 L1) for use in designing vaccine for prevention virus associated cell proliferative disorders
04/20/2010US7700092 Pneumovirus NS proteins antagonize the interferon IFN response
04/15/2010US20100093841 Cell culture system of a hepatitis c genotype 3a and 2a chimera
04/15/2010US20100093059 Method for the Preparation of Sulfated Cellulose Membranes and Sulfated Cellulose Membranes
04/15/2010US20100093058 High Transgene Expression Of A Pseudotyped Adeno-Associated Virus Type
04/15/2010US20100092515 Herpes simplex viruses and methods of viral replication
04/15/2010US20100092513 Methods and compositions for inducing an immune response to HIV and models for testing
04/15/2010US20100092510 Turkey herpesvirus vectored recombinant containing avian influenza genes
04/15/2010US20100092508 Molecular Antigen Arrays
04/15/2010US20100092502 Modified hiv env polypeptides
04/15/2010US20100092431 Edwardsiella Ictaluri Bacteriophage and Uses Thereof
04/15/2010US20100092430 Attenuated oncolytic paramyxoviruses encoding avian cytokines
04/14/2010EP2173866A2 Vaccine production for pathogenic bird viral diseases
04/14/2010EP2173865A2 Apparatus and method for harvesting biologics from eggs
04/14/2010EP1797174B1 Method for preparing viral material
04/14/2010EP1002055B2 Recovery of virus from cell culture using a hypertonic salt solution
04/14/2010CN101694832A Method and combination for making multi-length thin film
04/14/2010CN101693894A Avian influenza virus H5N1 pseudotype virus, process for preparation and special DNA fragment thereof
04/14/2010CN101693887A Fast cultivation and identification method of high throughput virus and applications thereof
04/14/2010CN101693672A Peptidomimetic protease inhibitors
04/13/2010US7695939 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
04/13/2010US7695724 Recombinant rabies virus compositions
04/13/2010CA2383372C Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression
04/13/2010CA2244946C Gene expression vectors which generate an antigen specific immune response and methods of using the same
04/13/2010CA2232264C Variants of human recombinant interferon-.gamma. (rhu-ifn-.gamma.) with increased thermal stability
04/08/2010WO2010039056A1 Method for producing a nucleoprotein nanoparticle
04/08/2010WO2010038719A1 Method for producing purified influenza virus antigen
04/08/2010WO2010037403A1 Hepatitis c virus expressing reporter tagged ns5a protein
04/08/2010US20100087621 Immune reactivity to her-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
04/08/2010US20100087382 Inhibitors of Hepatitis C NS3 Protease
04/08/2010US20100086565 Vectors for expression of hml-2 polypeptides
04/08/2010US20100086564 West Nile Virus Vaccine
04/08/2010DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors
04/07/2010EP2172543A1 Process for the replication of influenza viruses in cell culture, and the influenza viruses obtainable by the process
04/07/2010EP2172227A1 Methods for reducing adventitious agents or toxins in a sample and cell culture reagents produced thereby
04/07/2010EP2171046A2 Bacteriophage with enhanced lytic activity
04/07/2010EP2170935A2 Hpiv-2 variants and medical applications thereof
04/07/2010EP2170933A1 Novel plant virus designated tomato marchitez virus
04/07/2010EP2170382A1 An attenuated influenza virus and a live vaccine comprising the same
04/07/2010EP1907536B1 Cell line for producing coronaviruses
04/07/2010EP1723168B1 Beak and feather disease virus sequences, compositions and vaccines and the use thereof in therapy, diagnosis and assays
04/07/2010EP1175497B1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
04/07/2010CN101690808A Method for preparing swine fever-pseudorabies bigeminal live vaccine and product thereof
04/06/2010US7691627 Nucleic acid sequences encoding D1 and D1/D2 domains of human coxsackievirus and adenovirus receptor (CAR)
04/06/2010US7691386 comprising a papillomavirus L1 product and a papillomavirus L2 fusion product; drug delivery
04/06/2010CA2617830C Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome
04/06/2010CA2303477C Chimaeric adenoviruses
04/06/2010CA2193491C Replication-competent herpes simplex virus mediates destruction of neoplastic cells
04/01/2010WO2010036774A1 Methods for purification of viruses
04/01/2010WO2010036760A1 Methods for cultivating cells, propagating and purifying viruses
04/01/2010US20100080825 Filovirus vectors and noninfectious filovirus-based particles
04/01/2010US20100080824 A formulation comprising a cell culture extract of an isolated virus is identified to be morphologically and phylogenetically similar to the known member of coronaviruses; kits comprising containers containing the formulation used in medical diagnosis, as vaccines and antibodies
04/01/2010US20100080775 Recombinant adenoviruses encoding the specific iodine transporter (nis)
04/01/2010CA2738024A1 Methods for purification of viruses
04/01/2010CA2738022A1 Methods for cultivating cells, propagating and purifying viruses
03/2010
03/31/2010EP2169073A1 Vector for the preparation of immunotherapeutical compositions
03/31/2010EP1278878B1 Codon optimized eiav vectors
03/31/2010CN101688197A Hcv gene
03/31/2010CN101688188A Method for purifying a viral suspension
03/31/2010CN101688187A Formulation of sugar solutions for continuous ultracentrifugation for virus purification
03/31/2010CN101688186A Two-step temperature profile for the propagation of viruses
03/31/2010CN101688185A Production of a homogeneous cell line highly permissive to porcine circovirus type 2 (pcv2) infection
03/31/2010CN101688184A recombinant rhinovirus vectors
03/31/2010CN101688182A Immortalized avian cell lines
03/31/2010CN101684477A Novel tumor target gene therapy system based on gland virus replication and recombination
03/31/2010CN101683523A Preparation method of prostatic cancer specific DC cell vaccine which is insensitive to TGF-belta
03/30/2010US7687611 Assay for the separation and quantification of hemagglutinin antigens
03/30/2010US7687240 Process for increasing RSV surface glycoprotein yields using a mutant strain of RSV
03/25/2010WO2010033486A1 Vaccines containing canine parvovirus genetic variants
03/25/2010WO2010031837A1 Viral strains derived from the vaccinia virus lister vacv-107 and uses thereof
03/25/2010WO2010031783A1 Mutant pestivirus with mutations in core gene and ns3 region
03/25/2010WO2009136382A3 Antibodies to receptor of advanced glycation end products (rage) and uses thereof
03/25/2010US20100075399 Methods for protein refolding
03/25/2010US20100075398 Bacteriophage Preparations and Method of Use Thereof
03/25/2010US20100075301 Methods for Generation of Reporter Phages and Immobilization of Active Bacteriophages on a Polymer Surface
03/25/2010US20100075299 Detection and use of antiviral resistance mutations
03/25/2010US20100074889 4'-allene-substituted nucleoside derivatives
03/25/2010US20100074869 Multifunctional Cytokines
03/25/2010CA2737378A1 Vaccines containing canine parvovirus genetic variants
03/24/2010EP2166107A1 Lentiviral vectors for the expression of shRNA
03/24/2010EP1180938B1 Agents, compositions and methods utilizing the same useful in treating or preventing alzheimer disease
03/24/2010CN101679954A Methods and compositions for live attenuated viruses
03/24/2010CN101679953A Mutant reoviruses and methods of making and using
03/24/2010CN101676389A Modified vaccinia ankara virus variant
03/24/2010CN101676388A Avian cell lines for the production of useful substances
03/23/2010US7682618 Generation of virus-like particles and use as panfilovirus vaccine
03/23/2010CA2225388C Low pathogenicity prrs live virus vaccines and methods of preparation thereof
03/18/2010WO2009138752A3 Fish vaccine
03/18/2010US20100069304 Protective effects of inhibiting the interaction of calmodulin and mutant huntingtin protein
03/18/2010US20100068787 Novel Staphylococcus aureus: Bacteriophage and Uses Thereof
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 267